Abbott Laboratories: Organic Growth Will Be Key To Q1 Earnings (NYSE:ABT)

Date:

Share post:


MCCAIG

In my previous Abbott Laboratories (NYSE:ABT) article, I discussed the company’s Q3 2023 earnings, revealing a significant resurgence in their primary business segments. The decline in COVID-19 testing-related revenue did not stop Abbott from pulling in $10.1B for the quarterreportedApril 17th

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

7 Best Accounting Website Examples to Inspire Your Site Audit in 2024

In finance, well-crafted accounting websites serve as a digital front and a crucial tool for business development...

Israel’s Defense Ministry sees startups as vital for war effort – Investorempires.com

<!-- Israel’s Defense Ministry sees startups as vital for war effort – Investorempires.com ...

Your Ticket to Holiday Savings Starts with Costco

Disclosure: Our goal is to feature products...

ESPN Wants to Leverage AI to Create 'Personalized' SportsCenter Feeds

The plan is for fans to customize searches to prioritize their favorite teams, sports and content on...